HomeCompareSYK vs ACN

SYK vs ACN: Dividend Comparison 2026

SYK yields 1.04% · ACN yields 3.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACN wins by $45.29M in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
ACN
ACN
● Live price
3.30%
Share price
$197.55
Annual div
$6.52
5Y div CAGR
85.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.34M
Annual income
$40,254,140.02
Full ACN calculator →

Portfolio growth — SYK vs ACN

📍 ACN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKACN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + ACN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
ACN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
ACN
Annual income on $10K today (after 15% tax)
$280.54/yr
After 10yr DRIP, annual income (after tax)
$34,216,019.02/yr
At 15% tax rate, ACN beats the other by $34,208,978.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + ACN for your $10,000?

SYK: 50%ACN: 50%
100% ACN50/50100% SYK
Portfolio after 10yr
$22.69M
Annual income
$20,131,211.50/yr
Blended yield
88.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ACN right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
ACN
Analyst Ratings
39
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$299.92
+51.8% upside vs current
Range: $265.00 — $330.00
Altman Z
4.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
ACN buys
0
No recent congressional trades found for SYK or ACN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKACN
Forward yield1.04%3.30%
Annual dividend / share$3.40$6.52
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%85.1%
Portfolio after 10y$43.3K$45.34M
Annual income after 10y$8,282.98$40,254,140.02
Total dividends collected$21.0K$44.91M
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusBuyBuy
Analyst price target$428.67$299.92

Year-by-year: SYK vs ACN ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrACN PortfolioACN Income/yrGap
1← crossover$10,852$152.43$11,311$610.91$459.00ACN
2$11,838$226.03$13,298$1,195.36$1.5KACN
3$13,004$336.89$16,660$2,431.14$3.7KACN
4$14,420$505.63$23,095$5,268.91$8.7KACN
5$16,195$766.09$37,347$12,635.37$21.2KACN
6$18,504$1,175.64$75,308$35,346.62$56.8KACN
7$21,635$1,835.40$203,877$123,297.57$182.2KACN
8$26,082$2,932.10$795,585$577,436.45$769.5KACN
9$32,737$4,829.68$4,749,302$3,898,026.13$4.72MACN
10$43,312$8,282.98$45,335,893$40,254,140.02$45.29MACN

SYK vs ACN: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

ACNTechnology

Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management, intelligent automation comprises robotic process automation, natural language processing, and virtual agents, and liquid application management services, as well as program, project, and service management services; strategy consulting services; critical data elements, data management and governance, data platform and architecture, product-based organization and skills, business adoption, and value realization services; engineering, and research and development digitization; smart connected product design and development; product platform engineering and modernization; product as-a-service enablement; products related to production and operations; autonomous robotics systems; the digital transformation of capital projects; and digital industrial workforce solutions. It also provides data-enabled operating models; technology consulting and artificial intelligence services; services related to talent and organization/human potential; digital commerce; infrastructure services, such as hybrid cloud, network, digital workplace and collaboration, service and experience management, infrastructure as code, and managed edge and IoT devices; cyber defense, applied cybersecurity, managed security, OT security, security strategy and risk, and industry security products; services related to technology innovation; and intelligent automation services. In addition, the company offers cloud, ecosystem, marketing, supply chain management, zero-based budgeting, customer experience, finance consulting, mergers and acquisitions, and sustainability services. Accenture plc was founded in 1951 and is based in Dublin, Ireland.

Full ACN Calculator →
📬

Get this SYK vs ACN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.